- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Syncom Formulations covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (63), financial health (5), director (35) and company-foundation signals.
- Operating for 38+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Loss-making in FY 2025.
- Negative net worth - capital eroded by losses.
- 11 directors on the board.
- Director ANKIT JAIN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Syncom Formulations
Syncom Formulations is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24239MH1988PLC047759). Business overview includes Pharma (Drug Formulation & Development), incorporated on June 21, 1988 (38+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status.
- Location 7, Niraj Industrial Estate, Off Mahakali Caves Road Andheri (East), Mumbai, Maharashtra - 400093
- Website sfil.in
Financial Performance of Syncom Formulations
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Syncom Formulations (11)
Charges of Syncom Formulations
| Lender | Amount | Status |
|---|---|---|
|
Hdfc Bank Limited
Creation Date: 01 Oct 2025 |
9.50 cr | Open |
|
Hdfc Bank Limited
Creation Date: 28 Dec 2020 |
100.00 cr | Closed |
|
Dena Bank
Creation Date: 23 May 2002 |
12.77 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 77.26 |
| Trade | - | 21.40 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Syncom Formulations
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
